Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 410
Filter
Add more filters

Publication year range
1.
Annu Rev Immunol ; 33: 417-43, 2015.
Article in English | MEDLINE | ID: mdl-25861977

ABSTRACT

Interleukin-27 (IL-27) is a cytokine with strikingly diverse influences on the immune response. Although it was initially linked with the development of Th1 responses, it is now recognized as a potent antagonist of different classes of inflammation through its ability to directly modify CD4(+) and CD8(+) T cell effector functions, to induce IL-10, and to promote specialized T regulatory cell responses. Although this aspect of IL-27 biology has provided insights into how the immune system prevents hyperactivity in the setting of infectious and autoimmune inflammation, in vaccination and cancer models the stimulatory effects of IL-27 on CD8(+) T cell function appear prominent. Additionally, associations between IL-27 and antibody-mediated disease have led to an interest in defining the impact of IL-27 on innate immunity and humoral responses in different disease states. The maturation of this literature has been accompanied by attempts to translate these findings from experimental models into human diseases and by efforts to define where IL-27 might represent a viable therapeutic target.


Subject(s)
Immunity , Interleukin-27/physiology , Adaptive Immunity , Animals , Humans , Immunity, Innate , Inflammation/etiology , Inflammation/metabolism , Interleukin-27/chemistry , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Translational Research, Biomedical
2.
Nat Immunol ; 23(6): 947-959, 2022 06.
Article in English | MEDLINE | ID: mdl-35552540

ABSTRACT

Inflammation is an important component of fibrosis but immune processes that orchestrate kidney fibrosis are not well understood. Here we apply single-cell sequencing to a mouse model of kidney fibrosis. We identify a subset of kidney tubule cells with a profibrotic-inflammatory phenotype characterized by the expression of cytokines and chemokines associated with immune cell recruitment. Receptor-ligand interaction analysis and experimental validation indicate that CXCL1 secreted by profibrotic tubules recruits CXCR2+ basophils. In mice, these basophils are an important source of interleukin-6 and recruitment of the TH17 subset of helper T cells. Genetic deletion or antibody-based depletion of basophils results in reduced renal fibrosis. Human kidney single-cell, bulk gene expression and immunostaining validate a function for basophils in patients with kidney fibrosis. Collectively, these studies identify basophils as contributors to the development of renal fibrosis and suggest that targeting these cells might be a useful clinical strategy to manage chronic kidney disease.


Subject(s)
Basophils , Renal Insufficiency, Chronic , Animals , Fibrosis , Humans , Kidney/metabolism , Kidney Tubules , Mice , Renal Insufficiency, Chronic/metabolism , Single-Cell Analysis
3.
Nat Immunol ; 23(5): 743-756, 2022 05.
Article in English | MEDLINE | ID: mdl-35437326

ABSTRACT

Phenotypic and transcriptional profiling of regulatory T (Treg) cells at homeostasis reveals that T cell receptor activation promotes Treg cells with an effector phenotype (eTreg) characterized by the production of interleukin-10 and expression of the inhibitory receptor PD-1. At homeostasis, blockade of the PD-1 pathway results in enhanced eTreg cell activity, whereas during infection with Toxoplasma gondii, early interferon-γ upregulates myeloid cell expression of PD-L1 associated with reduced Treg cell populations. In infected mice, blockade of PD-L1, complete deletion of PD-1 or lineage-specific deletion of PD-1 in Treg cells prevents loss of eTreg cells. These interventions resulted in a reduced ratio of pathogen-specific effector T cells: eTreg cells and increased levels of interleukin-10 that mitigated the development of immunopathology, but which could compromise parasite control. Thus, eTreg cell expression of PD-1 acts as a sensor to rapidly tune the pool of eTreg cells at homeostasis and during inflammatory processes.


Subject(s)
B7-H1 Antigen , Programmed Cell Death 1 Receptor , T-Lymphocytes, Regulatory , Toxoplasmosis, Animal , Animals , B7-H1 Antigen/immunology , Homeostasis , Interleukin-10/immunology , Mice , Programmed Cell Death 1 Receptor/immunology , T-Lymphocytes, Regulatory/immunology , Toxoplasma/immunology , Toxoplasmosis, Animal/immunology
4.
Nat Immunol ; 18(11): 1271, 2017 10 18.
Article in English | MEDLINE | ID: mdl-29044237

ABSTRACT

This corrects the article DOI: 10.1038/ni.3153.

5.
Immunity ; 53(1): 19-25, 2020 07 14.
Article in English | MEDLINE | ID: mdl-32610079

ABSTRACT

The elevated circulating levels of cytokines associated with a variety of infectious and immune-mediated conditions are frequently termed a cytokine storm. Here, we explain the protective functions of cytokines in "ideal" responses; the multi-factorial origins that can drive these responses to become pathological; and how this ultimately leads to vascular damage, immunopathology, and worsening clinical outcomes.


Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/pathology , Cytokine Release Syndrome/blood , Cytokine Release Syndrome/pathology , Cytokines/blood , Pneumonia, Viral/pathology , COVID-19 , Coronavirus Infections/blood , Coronavirus Infections/immunology , Humans , Inflammation/blood , Inflammation/pathology , Pandemics , Pneumonia, Viral/blood , Pneumonia, Viral/immunology , SARS-CoV-2
6.
Nat Immunol ; 17(6): 626-35, 2016 06.
Article in English | MEDLINE | ID: mdl-27111143

ABSTRACT

Innate lymphoid cells (ILCs) are critical mediators of mucosal immunity, and group 1 ILCs (ILC1 cells) and group 3 ILCs (ILC3 cells) have been shown to be functionally plastic. Here we found that group 2 ILCs (ILC2 cells) also exhibited phenotypic plasticity in response to infectious or noxious agents, characterized by substantially lower expression of the transcription factor GATA-3 and a concomitant switch to being ILC1 cells that produced interferon-γ (IFN-γ). Interleukin 12 (IL-12) and IL-18 regulated this conversion, and during viral infection, ILC2 cells clustered within inflamed areas and acquired an ILC1-like phenotype. Mechanistically, these ILC1 cells augmented virus-induced inflammation in a manner dependent on the transcription factor T-bet. Notably, IL-12 converted human ILC2 cells into ILC1 cells, and the frequency of ILC1 cells in patients with chronic obstructive pulmonary disease (COPD) correlated with disease severity and susceptibility to exacerbations. Thus, functional plasticity of ILC2 cells exacerbates anti-viral immunity, which may have adverse consequences in respiratory diseases such as COPD.


Subject(s)
Haemophilus Infections/immunology , Haemophilus influenzae/immunology , Influenza A virus/immunology , Lung/immunology , Lymphocytes/immunology , Orthomyxoviridae Infections/immunology , Pulmonary Disease, Chronic Obstructive/immunology , Staphylococcal Infections/immunology , Staphylococcus aureus/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Aged , Animals , Cell Differentiation , Cell Plasticity/immunology , Cells, Cultured , Cytokines/metabolism , Female , GATA3 Transcription Factor/genetics , GATA3 Transcription Factor/metabolism , Gene Expression Regulation , Humans , Immunity, Innate , Inflammation Mediators/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Phenotype , Smoking/adverse effects , T-Box Domain Proteins/genetics , T-Box Domain Proteins/metabolism
7.
Immunity ; 50(4): 851-870, 2019 04 16.
Article in English | MEDLINE | ID: mdl-30995503

ABSTRACT

The discovery of interleukin (IL)-6 and its receptor subunits provided a foundation to understand the biology of a group of related cytokines: IL-12, IL-23, and IL-27. These family members utilize shared receptors and cytokine subunits and influence the outcome of cancer, infection, and inflammatory diseases. Consequently, many facets of their biology are being therapeutically targeted. Here, we review the landmark discoveries in this field, the combinatorial biology inherent to this family, and how patient datasets have underscored the critical role of these pathways in human disease. We present significant knowledge gaps, including how similar signals from these cytokines can mediate distinct outcomes, and discuss how a better understanding of the biology of the IL-12 family provides new therapeutic opportunities.


Subject(s)
Cytokines/immunology , Interleukin-12/immunology , Multigene Family/immunology , Animals , Autoimmune Diseases/immunology , Autoimmune Diseases/therapy , Cytokines/antagonists & inhibitors , Cytokines/genetics , Humans , Immunity, Cellular , Inflammation/immunology , Interleukin-12/antagonists & inhibitors , Interleukin-12/genetics , Interleukin-27/therapeutic use , Lymphocyte Subsets/immunology , Lymphopoiesis , Mice , Mice, Knockout , Multigene Family/genetics , Neoplasms, Experimental/immunology , Neoplasms, Experimental/therapy , Protein Subunits , Structure-Activity Relationship
8.
Nat Immunol ; 16(5): 448-57, 2015 May.
Article in English | MEDLINE | ID: mdl-25898198

ABSTRACT

Interleukin 6 (IL-6) has a broad effect on cells of the immune system and those not of the immune system and often displays hormone-like characteristics that affect homeostatic processes. IL-6 has context-dependent pro- and anti-inflammatory properties and is now regarded as a prominent target for clinical intervention. However, the signaling cassette that controls the activity of IL-6 is complicated, and distinct intervention strategies can inhibit this pathway. Clinical experience with antagonists of IL-6 has raised new questions about how and when to block this cytokine to improve disease outcome and patient wellbeing. Here we discuss the effect of IL-6 on innate and adaptive immunity and the possible advantages of various antagonists of IL-6 and consider how the immunobiology of IL-6 may inform clinical decisions.


Subject(s)
B-Lymphocytes/immunology , Immunotherapy/trends , Inflammatory Bowel Diseases/therapy , Interleukin-6/physiology , Psoriasis/therapy , Receptors, Interleukin-6/metabolism , Spondylitis, Ankylosing/therapy , Adaptive Immunity , Animals , Antibodies, Blocking/pharmacology , Drug Evaluation, Preclinical , Homeostasis , Humans , Immunity, Innate , Inflammatory Bowel Diseases/immunology , Interleukin-6/antagonists & inhibitors , Psoriasis/immunology , Signal Transduction , Spondylitis, Ankylosing/immunology
9.
PLoS Pathog ; 20(5): e1011820, 2024 May.
Article in English | MEDLINE | ID: mdl-38718306

ABSTRACT

The production of IFN-γ is crucial for control of multiple enteric infections, but its impact on intestinal epithelial cells (IEC) is not well understood. Cryptosporidium parasites exclusively infect epithelial cells and the ability of interferons to activate the transcription factor STAT1 in IEC is required for parasite clearance. Here, the use of single cell RNA sequencing to profile IEC during infection revealed an increased proportion of mid-villus enterocytes during infection and induction of IFN-γ-dependent gene signatures that was comparable between uninfected and infected cells. These analyses were complemented by in vivo studies, which demonstrated that IEC expression of the IFN-γ receptor was required for parasite control. Unexpectedly, treatment of Ifng-/- mice with IFN-γ showed the IEC response to this cytokine correlates with a delayed reduction in parasite burden but did not affect parasite development. These data sets provide insight into the impact of IFN-γ on IEC and suggest a model in which IFN-γ signalling to uninfected enterocytes is important for control of Cryptosporidium.


Subject(s)
Cryptosporidiosis , Interferon-gamma , Intestinal Mucosa , Mice, Knockout , Animals , Interferon-gamma/metabolism , Interferon-gamma/immunology , Cryptosporidiosis/immunology , Cryptosporidiosis/parasitology , Mice , Intestinal Mucosa/parasitology , Intestinal Mucosa/metabolism , Intestinal Mucosa/immunology , Cryptosporidium , Epithelial Cells/parasitology , Epithelial Cells/metabolism , Epithelial Cells/immunology , Enterocytes/parasitology , Enterocytes/metabolism , Enterocytes/immunology , Mice, Inbred C57BL , Interferon gamma Receptor , STAT1 Transcription Factor/metabolism , Receptors, Interferon/metabolism , Receptors, Interferon/genetics , Signal Transduction
10.
Nat Immunol ; 15(12): 1099-100, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25396344

ABSTRACT

Chitinase-like proteins are associated with type 2 immune responses and the 'wound-healing' pathway, but their role has remained unclear. Studies have now highlighted their contribution to IL-17 production and their link to neutrophil activity required for the control of helminth infection.


Subject(s)
Chitinases/immunology , Glycoproteins/immunology , Lectins/immunology , Nematode Infections/immunology , Neutrophil Infiltration/immunology , beta-N-Acetylhexosaminidases/immunology , Animals , Chitinase-3-Like Protein 1
11.
Immunity ; 46(6): 891-909, 2017 06 20.
Article in English | MEDLINE | ID: mdl-28636958

ABSTRACT

The concept of immune privilege of the central nervous system (CNS) has dominated the study of inflammatory processes in the brain. However, clinically relevant models have highlighted that innate pathways limit pathogen invasion of the CNS and adaptive immunity mediates control of many neural infections. As protective responses can result in bystander damage, there are regulatory mechanisms that balance protective and pathological inflammation, but these mechanisms might also allow microbial persistence. The focus of this review is to consider the host-pathogen interactions that influence neurotropic infections and to highlight advances in our understanding of innate and adaptive mechanisms of resistance as key determinants of the outcome of CNS infection. Advances in these areas have broadened our comprehension of how the immune system functions in the brain and can readily overcome immune privilege.


Subject(s)
Adaptive Immunity , Central Nervous System/immunology , Encephalitis/immunology , Immune System , Immunity, Innate , Infections/immunology , Meningitis/immunology , Animals , Blood-Brain Barrier/immunology , Host-Pathogen Interactions , Humans , Immune Tolerance
12.
Chem Soc Rev ; 53(3): 1354-1374, 2024 Feb 05.
Article in English | MEDLINE | ID: mdl-38116736

ABSTRACT

The accumulation of amyloid fibrils is characteristic of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease. Detecting these fibrils with fluorescent or radiolabelled ligands is one strategy for diagnosing and better understanding these diseases. A vast number of amyloid-binding ligands have been reported in the literature as a result. To obtain a better understanding of how amyloid ligands bind, we have compiled a database of 3457 experimental dissociation constants for 2076 unique amyloid-binding ligands. These ligands target Aß, tau, or αSyn fibrils, as well as relevant biological samples including AD brain homogenates. From this database significant variation in the reported dissociation constants of ligands was found, possibly due to differences in the morphology of the fibrils being studied. Ligands were also found to bind to Aß(1-40) and Aß(1-42) fibrils with similar affinities, whereas a greater difference was found for binding to Aß and tau or αSyn fibrils. Next, the binding of ligands to fibrils was shown to be largely limited by the hydrophobic effect. Some Aß ligands do not fit into this hydrophobicity-limited model, suggesting that polar interactions can play an important role when binding to this target. Finally several binding site models were outlined for amyloid fibrils that describe what ligands target what binding sites. These models provide a foundation for interpreting and designing site-specific binding assays.


Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Humans , Amyloid beta-Peptides/metabolism , Protein Aggregates , Amyloid/chemistry , Alzheimer Disease/diagnosis , Alzheimer Disease/metabolism , Amyloidogenic Proteins
13.
J Am Chem Soc ; 146(13): 9326-9334, 2024 Apr 03.
Article in English | MEDLINE | ID: mdl-38529806

ABSTRACT

Recognition-encoded melamine oligomers (REMO) are synthetic polymers that feature an alternating 1,3,5-triazine-piperazine backbone and side-chains equipped with either a phenol or phosphine oxide recognition unit. An automated method for the solid-phase synthesis (SPS) of REMO of any specified sequence has been developed starting from dichlorotriazine monomer building blocks. Complementary homo-oligomers with either six phenols or six phosphine oxides were synthesized and shown to form a stable duplex in nonpolar solvents by NMR denaturation experiments. The duplex was covalently trapped by equipping the ends of the oligomers with an azide and an alkyne group and using a copper-catalyzed alkyne-azide cycloaddition (CuAAC) reaction. The SPS methodology was adapted to synthesize mixed sequence libraries by using a mixture of two different dichlorotriazine building blocks in each coupling cycle of an oligomer synthesis. The resulting libraries contain statistical mixtures of all possible sequences. The self-assembly properties of these libraries were screened by using the CuAAC reaction to trap any duplexes present. In mixed sequence libraries of 6-mers, the trapping experiments showed that only sequence-complementary oligomers formed duplexes at micromolar concentrations in dichloromethane. The automated synthesis approach developed here provides access to large libraries of mixed sequence synthetic polymers, and the covalent trapping experiment provides a convenient tool for screening functional properties of mixtures. The results suggest high-fidelity sequence-selective duplex formation in mixtures of 6-mer sequences of the REMO architecture.

14.
PLoS Pathog ; 18(5): e1010003, 2022 05.
Article in English | MEDLINE | ID: mdl-35584177

ABSTRACT

Cryptosporidium is a leading cause of severe diarrhea and diarrheal-related death in children worldwide. As an obligate intracellular parasite, Cryptosporidium relies on intestinal epithelial cells to provide a niche for its growth and survival, but little is known about the contributions that the infected cell makes to this relationship. Here we conducted a genome wide CRISPR/Cas9 knockout screen to discover host genes that influence Cryptosporidium parvum infection and/or host cell survival. Gene enrichment analysis indicated that the host interferon response, glycosaminoglycan (GAG) and glycosylphosphatidylinositol (GPI) anchor biosynthesis are important determinants of susceptibility to C. parvum infection and impact on the viability of host cells in the context of parasite infection. Several of these pathways are linked to parasite attachment and invasion and C-type lectins on the surface of the parasite. Evaluation of transcript and protein induction of innate interferons revealed a pronounced type III interferon response to Cryptosporidium in human cells as well as in mice. Treatment of mice with IFNλ reduced infection burden and protected immunocompromised mice from severe outcomes including death, with effects that required STAT1 signaling in the enterocyte. Initiation of this type III interferon response was dependent on sustained intracellular growth and mediated by the pattern recognition receptor TLR3. We conclude that host cell intrinsic recognition of Cryptosporidium results in IFNλ production critical to early protection against this infection.


Subject(s)
Cryptosporidiosis , Cryptosporidium parvum , Interferons , Toll-Like Receptor 3 , Animals , Cryptosporidiosis/genetics , Cryptosporidiosis/parasitology , Cryptosporidium parvum/genetics , Cryptosporidium parvum/immunology , Diarrhea , Interferons/immunology , Mice , Toll-Like Receptor 3/immunology , Interferon Lambda
15.
PLoS Pathog ; 18(6): e1010296, 2022 06.
Article in English | MEDLINE | ID: mdl-35727849

ABSTRACT

Initial TCR engagement (priming) of naive CD8+ T cells results in T cell expansion, and these early events influence the generation of diverse effector and memory populations. During infection, activated T cells can re-encounter cognate antigen, but how these events influence local effector responses or formation of memory populations is unclear. To address this issue, OT-I T cells which express the Nur77-GFP reporter of TCR activation were paired with the parasite Toxoplasma gondii that expresses OVA to assess how secondary encounter with antigen influences CD8+ T cell responses. During acute infection, TCR stimulation in affected tissues correlated with parasite burden and was associated with markers of effector cells while Nur77-GFP- OT-I showed signs of effector memory potential. However, both Nur77-GFP- and Nur77-GFP+ OT-I from acutely infected mice formed similar memory populations when transferred into naive mice. During the chronic stage of infection in the CNS, TCR activation was associated with large scale transcriptional changes and the acquisition of an effector T cell phenotype as well as the generation of a population of CD103+ CD69+ Trm like cells. While inhibition of parasite replication resulted in reduced effector responses it did not alter the Trm population. These data sets highlight that recent TCR activation contributes to the phenotypic heterogeneity of the CD8+ T cell response but suggest that this process has a limited impact on memory populations at acute and chronic stages of infection.


Subject(s)
Toxoplasma , Toxoplasmosis , Animals , CD8-Positive T-Lymphocytes , Immunologic Memory , Mice , Receptors, Antigen, T-Cell
17.
Nat Immunol ; 13(3): 290-9, 2012 Feb 05.
Article in English | MEDLINE | ID: mdl-22306691

ABSTRACT

Interleukin 35 (IL-35) belongs to the IL-12 family of heterodimeric cytokines but has a distinct functional profile. IL-35 suppresses T cell proliferation and converts naive T cells into IL-35-producing induced regulatory T cells (iTr35 cells). Here we found that IL-35 signaled through a unique heterodimer of receptor chains IL-12Rß2 and gp130 or homodimers of each chain. Conventional T cells were sensitive to IL-35-mediated suppression in the absence of one receptor chain but not both receptor chains, whereas signaling through both chains was required for IL-35 expression and conversion into iTr35 cells. Signaling through the IL-35 receptor required the transcription factors STAT1 and STAT4, which formed a unique heterodimer that bound to distinct sites in the promoters of the genes encoding the IL-12 subunits p35 and Ebi3. This unconventional mode of signaling, distinct from that of other members of the IL-12 family, may broaden the spectrum and specificity of IL-35-mediated suppression.


Subject(s)
Receptors, Interleukin-1/immunology , Receptors, Interleukin/immunology , Signal Transduction , Animals , Cytokine Receptor gp130/immunology , Interleukins/immunology , Mice , Mice, Knockout , Models, Molecular , Protein Multimerization , Protein Structure, Quaternary , Receptors, Interleukin/chemistry , Receptors, Interleukin/deficiency , Receptors, Interleukin/metabolism , Receptors, Interleukin-1/chemistry , Receptors, Interleukin-1/deficiency , Receptors, Interleukin-1/metabolism , Receptors, Interleukin-12/immunology , STAT1 Transcription Factor/immunology , STAT4 Transcription Factor/immunology
18.
Acc Chem Res ; 56(6): 712-727, 2023 Mar 21.
Article in English | MEDLINE | ID: mdl-36894535

ABSTRACT

ConspectusNucleic acids represent a unique class of highly programmable molecules, where the sequence of monomer units incorporated into the polymer chain can be read through duplex formation with a complementary oligomer. It should be possible to encode information in synthetic oligomers as a sequence of different monomer units in the same way that the four different bases program information into DNA and RNA. In this Account, we describe our efforts to develop synthetic duplex-forming oligomers composed of sequences of two complementary recognition units that can base-pair in organic solvents through formation of a single H-bond, and we outline some general guidelines for the design of new sequence-selective recognition systems.The design strategy has focused on three interchangeable modules that control recognition, synthesis, and backbone geometry. For a single H-bond to be effective as a base-pairing interaction, very polar recognition units, such as phosphine oxide and phenol, are required. Reliable base-pairing in organic solvents requires a nonpolar backbone, so that the only polar functional groups present are the donor and acceptor sites on the two recognition units. This criterion limits the range of functional groups that can be produced in the synthesis of oligomers. In addition, the chemistry used for polymerization should be orthogonal to the recognition units. Several compatible high yielding coupling chemistries that are suitable for the synthesis of recognition-encoded polymers are explored. Finally, the conformational properties of the backbone module play an important role in determining the supramolecular assembly pathways that are accessible to mixed sequence oligomers.Almost all complementary homo-oligomers will form duplexes provided the product of the association constant for formation of a base-pair and the effective molarity for the intramolecular base-pairing interactions that zip up the duplex is significantly greater than one. For these systems, the structure of the backbone does not play a major role, and the effective molarities for duplex formation tend to fall in the range 10-100 mM for both rigid and flexible backbones. For mixed sequences, intramolecular H-bonding interactions lead to folding. The competition between folding and duplex formation depends critically on the conformational properties of the backbone, and high-fidelity sequence-selective duplex formation is only observed for backbones that are sufficiently rigid to prevent short-range folding between bases that are close in sequence. The final section of the Account highlights the prospects for functional properties, other than duplex formation, that might be encoded with sequence.

19.
Immunity ; 42(5): 877-89, 2015 May 19.
Article in English | MEDLINE | ID: mdl-25992861

ABSTRACT

Interleukin-6 (IL-6) and IL-27 signal through a shared receptor subunit and employ the same downstream STAT transcription proteins, but yet are ascribed unique and overlapping functions. To evaluate the specificity and redundancy for these cytokines, we quantified their global transcriptomic changes and determined the relative contributions of STAT1 and STAT3 using genetic models and chromatin immunoprecipitation-sequencing (ChIP-seq) approaches. We found an extensive overlap of the transcriptomes induced by IL-6 and IL-27 and few examples in which the cytokines acted in opposition. Using STAT-deficient cells and T cells from patients with gain-of-function STAT1 mutations, we demonstrated that STAT3 is responsible for the overall transcriptional output driven by both cytokines, whereas STAT1 is the principal driver of specificity. STAT1 cannot compensate in the absence of STAT3 and, in fact, much of STAT1 binding to chromatin is STAT3 dependent. Thus, STAT1 shapes the specific cytokine signature superimposed upon STAT3's action.


Subject(s)
Chromatin/metabolism , Cytokines/metabolism , Gene Expression Regulation/immunology , Models, Immunological , STAT Transcription Factors/metabolism , Animals , CD4-Positive T-Lymphocytes/immunology , Cells, Cultured , Chromatin/chemistry , Humans , Immunoblotting , Mice , Mice, Inbred C57BL , Mutation , STAT1 Transcription Factor/chemistry , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/metabolism , STAT3 Transcription Factor/metabolism , Transcriptome
20.
Langmuir ; 40(27): 13753-13762, 2024 Jul 09.
Article in English | MEDLINE | ID: mdl-38934482

ABSTRACT

Lifshitz theory is widely used to calculate interfacial interaction energies and underpins established approaches to the interpretation of measurement data from experimental methods including the surface forces apparatus and the atomic force microscope. However, a significant limitation of Lifshitz theory is that it uses the bulk dielectric properties of the medium to predict the work of adhesion. Here, we demonstrate that a different approach, in which the interactions between molecules at surfaces and in the medium are described by a set of surface site interaction points (SSIPs), yields interaction free energies that are correlated better with experimentally determined values. The work of adhesion W(Lifshitz) between hydrocarbon surfaces was calculated in 260 liquids using Lifshitz theory and compared with interaction free energies ΔΔG calculated using the SSIP model. The predictions of these models diverge in significant ways. In particular, ΔΔG values for hydrocarbon surfaces are typically small and vary little, but in contrast, W(Lifshitz) values span 4 orders of magnitude. Moreover, the SSIP model yields significantly different ΔΔG values in some liquids for which Lifshitz theory predicts similar values of W(Lifshitz). These divergent predictions were tested using atomic force microscopy. Experimentally determined works of adhesion were closer to the values predicted using the SSIP model than Lifshitz theory. In mixtures of methanol and benzyl alcohol, even greater differences were found in the interaction energies calculated using the two models: the value of ΔΔG calculated using the SSIP model declines smoothly as the benzyl alcohol concentration increases, and values are well correlated with experimental data; however, W(Lifshitz) decreases to a minimum and then increases, reaching a larger value for benzyl alcohol than for methanol. We conclude that the SSIP model provides more reliable estimates of the work of adhesion than Lifshitz theory.

SELECTION OF CITATIONS
SEARCH DETAIL